Participants who took tirzepatide — which is sold as Zepbound by Eli Lilly — lost an average of 50 pounds over 72 weeks.

Those who take tirzepatide, the drug sold as Zepbound and Mounjaro, could lose more weight than those who take semaglutide, ...

New research has found that GLP-1 drugs can substantially reduce the risk of obesity-related cancers — and they’re more effective than getting weight loss surgery.

While the primary target for these medication is weight loss, it’s not the only metric by which the drugs should be evaluated ...

Medications such as Wegovy, Mounjaro and Ozempic were found to have disease-prevention qualities beyond their weight-loss ...

At the most basic level, losing weight requires a calorie deficit; you need to burn more than you consume. Working with a ...

A new study shows the tradeoff between power and efficiency in muscles is governed by proteins that form a molecular tuning ...